nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketobemidone—UGT1A9—Sorafenib—liver cancer	0.352	0.44	CbGbCtD
Ketobemidone—CYP2B6—Sorafenib—liver cancer	0.111	0.139	CbGbCtD
Ketobemidone—CYP2C8—Sorafenib—liver cancer	0.0844	0.105	CbGbCtD
Ketobemidone—CYP2C19—Sorafenib—liver cancer	0.0708	0.0885	CbGbCtD
Ketobemidone—CYP2B6—Doxorubicin—liver cancer	0.0676	0.0845	CbGbCtD
Ketobemidone—CYP2C9—Sorafenib—liver cancer	0.0589	0.0736	CbGbCtD
Ketobemidone—CYP3A4—Sorafenib—liver cancer	0.0342	0.0428	CbGbCtD
Ketobemidone—CYP3A4—Doxorubicin—liver cancer	0.0208	0.026	CbGbCtD
Ketobemidone—PTGS1—Metabolism—CYP1A1—liver cancer	2.7e-05	0.000135	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	2.69e-05	0.000135	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—BRAF—liver cancer	2.69e-05	0.000134	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—CYCS—liver cancer	2.68e-05	0.000134	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism of lipids and lipoproteins—ALB—liver cancer	2.66e-05	0.000133	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—HPGDS—liver cancer	2.65e-05	0.000133	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—ESR1—liver cancer	2.65e-05	0.000133	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—PSMA4—liver cancer	2.65e-05	0.000133	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—PSMD10—liver cancer	2.65e-05	0.000133	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—liver cancer	2.64e-05	0.000132	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—GGT1—liver cancer	2.63e-05	0.000132	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—GOT1—liver cancer	2.63e-05	0.000132	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—F2—liver cancer	2.62e-05	0.000131	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—PIK3CG—liver cancer	2.59e-05	0.00013	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—GOT2—liver cancer	2.58e-05	0.000129	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—IL2—liver cancer	2.52e-05	0.000126	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—TERT—liver cancer	2.51e-05	0.000126	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—MTHFR—liver cancer	2.51e-05	0.000126	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—PIK3CD—liver cancer	2.51e-05	0.000126	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—APC—liver cancer	2.51e-05	0.000125	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—PIK3CG—liver cancer	2.51e-05	0.000125	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—PPARG—liver cancer	2.5e-05	0.000125	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	2.49e-05	0.000125	CbGpPWpGaD
Ketobemidone—OPRD1—GPCR downstream signaling—PIK3CA—liver cancer	2.49e-05	0.000124	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—SERPINE1—liver cancer	2.49e-05	0.000124	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—CPT1B—liver cancer	2.48e-05	0.000124	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—GLUL—liver cancer	2.48e-05	0.000124	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—PPARA—liver cancer	2.47e-05	0.000123	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—KRAS—liver cancer	2.46e-05	0.000123	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—CYP2E1—liver cancer	2.42e-05	0.000121	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—HPGDS—liver cancer	2.42e-05	0.000121	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—liver cancer	2.41e-05	0.00012	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	2.4e-05	0.00012	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—NR1H4—liver cancer	2.39e-05	0.000119	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism of lipids and lipoproteins—ALB—liver cancer	2.37e-05	0.000119	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—PSMD10—liver cancer	2.37e-05	0.000118	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—PSMA4—liver cancer	2.37e-05	0.000118	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—GSTP1—liver cancer	2.36e-05	0.000118	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—BRAF—liver cancer	2.36e-05	0.000118	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—GSTA3—liver cancer	2.35e-05	0.000117	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	2.35e-05	0.000117	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—HMOX1—liver cancer	2.33e-05	0.000116	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—GOT2—liver cancer	2.3e-05	0.000115	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—KDR—liver cancer	2.3e-05	0.000115	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—MAPK14—liver cancer	2.28e-05	0.000114	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—PIK3CD—liver cancer	2.28e-05	0.000114	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—CYCS—liver cancer	2.27e-05	0.000113	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—PIK3CA—liver cancer	2.26e-05	0.000113	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—ALB—liver cancer	2.25e-05	0.000112	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—RAF1—liver cancer	2.24e-05	0.000112	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—ESR1—liver cancer	2.24e-05	0.000112	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—GGT1—liver cancer	2.23e-05	0.000111	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—GOT1—liver cancer	2.23e-05	0.000111	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	2.21e-05	0.000111	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—F2—liver cancer	2.21e-05	0.000111	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—PIK3CD—liver cancer	2.2e-05	0.00011	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	2.19e-05	0.00011	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—MTOR—liver cancer	2.19e-05	0.00011	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—PIK3CB—liver cancer	2.19e-05	0.00011	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR downstream signaling—PIK3CA—liver cancer	2.18e-05	0.000109	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—SERPINE1—liver cancer	2.18e-05	0.000109	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—GSTM1—liver cancer	2.17e-05	0.000109	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—CYP2E1—liver cancer	2.16e-05	0.000108	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism of lipids and lipoproteins—ALB—liver cancer	2.16e-05	0.000108	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—KRAS—liver cancer	2.16e-05	0.000108	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—PSMA4—liver cancer	2.16e-05	0.000108	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—PSMD10—liver cancer	2.16e-05	0.000108	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—GSTA4—liver cancer	2.15e-05	0.000107	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—APC—liver cancer	2.12e-05	0.000106	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—PIK3CG—liver cancer	2.12e-05	0.000106	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—PIK3CG—liver cancer	2.11e-05	0.000106	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—GOT2—liver cancer	2.1e-05	0.000105	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	2.09e-05	0.000105	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—GSTA2—liver cancer	2.09e-05	0.000105	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—HRAS—liver cancer	2.09e-05	0.000105	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—CYP1A1—liver cancer	2.06e-05	0.000103	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—CDKN1B—liver cancer	2.06e-05	0.000103	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—PPARG—liver cancer	2.04e-05	0.000102	CbGpPWpGaD
Ketobemidone—OPRD1—GPCR downstream signaling—AKT1—liver cancer	2.03e-05	0.000102	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—CYCS—liver cancer	2.02e-05	0.000101	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—GSTA1—liver cancer	2.02e-05	0.000101	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—CASP3—liver cancer	2.01e-05	0.000101	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—IL2—liver cancer	2.01e-05	0.000101	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—IL6—liver cancer	2e-05	0.0001	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—GSTP1—liver cancer	2e-05	0.0001	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—NAT2—liver cancer	2e-05	9.99e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—BRAF—liver cancer	1.99e-05	9.96e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—GOT1—liver cancer	1.99e-05	9.94e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—GGT1—liver cancer	1.99e-05	9.94e-05	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—PIK3CB—liver cancer	1.98e-05	9.93e-05	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—PIK3CA—liver cancer	1.98e-05	9.91e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—CYP2E1—liver cancer	1.97e-05	9.87e-05	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—HMOX1—liver cancer	1.97e-05	9.86e-05	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—RAF1—liver cancer	1.97e-05	9.84e-05	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—CCND1—liver cancer	1.96e-05	9.81e-05	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—JUN—liver cancer	1.96e-05	9.79e-05	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—CTNNB1—liver cancer	1.94e-05	9.71e-05	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—PIK3CB—liver cancer	1.92e-05	9.61e-05	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—MTOR—liver cancer	1.92e-05	9.61e-05	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—MTHFR—liver cancer	1.92e-05	9.59e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—ALDOB—liver cancer	1.91e-05	9.57e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	1.91e-05	9.56e-05	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—MMP9—liver cancer	1.9e-05	9.52e-05	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—CDKN1A—liver cancer	1.9e-05	9.49e-05	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—PPARA—liver cancer	1.88e-05	9.41e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—PIK3CD—liver cancer	1.86e-05	9.31e-05	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—PIK3CD—liver cancer	1.86e-05	9.29e-05	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—MAPK8—liver cancer	1.85e-05	9.26e-05	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—AKT1—liver cancer	1.85e-05	9.24e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—CYCS—liver cancer	1.85e-05	9.23e-05	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR downstream signaling—PIK3CA—liver cancer	1.84e-05	9.23e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—SERPINE1—liver cancer	1.84e-05	9.21e-05	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—GSTM1—liver cancer	1.84e-05	9.19e-05	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—HRAS—liver cancer	1.83e-05	9.17e-05	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—ALB—liver cancer	1.83e-05	9.17e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—CRABP1—liver cancer	1.83e-05	9.13e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—KRAS—liver cancer	1.82e-05	9.12e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—GGT1—liver cancer	1.81e-05	9.06e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—GOT1—liver cancer	1.81e-05	9.06e-05	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—CDKN1B—liver cancer	1.8e-05	9.02e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—GSTP1—liver cancer	1.78e-05	8.93e-05	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR downstream signaling—AKT1—liver cancer	1.78e-05	8.92e-05	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—CASP3—liver cancer	1.77e-05	8.84e-05	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—IL2—liver cancer	1.76e-05	8.82e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—HMOX1—liver cancer	1.76e-05	8.8e-05	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—IL6—liver cancer	1.75e-05	8.78e-05	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—CYP1A1—liver cancer	1.74e-05	8.71e-05	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—CCND1—liver cancer	1.72e-05	8.6e-05	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—JUN—liver cancer	1.72e-05	8.58e-05	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—VEGFA—liver cancer	1.71e-05	8.55e-05	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—CTNNB1—liver cancer	1.7e-05	8.52e-05	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—STAT3—liver cancer	1.69e-05	8.47e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—PIK3CA—liver cancer	1.67e-05	8.38e-05	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—MMP9—liver cancer	1.67e-05	8.35e-05	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—CDKN1A—liver cancer	1.66e-05	8.32e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—RAF1—liver cancer	1.66e-05	8.32e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—GSTM1—liver cancer	1.64e-05	8.2e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—GSTP1—liver cancer	1.63e-05	8.14e-05	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—MTHFR—liver cancer	1.62e-05	8.12e-05	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—MAPK8—liver cancer	1.62e-05	8.12e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—MTOR—liver cancer	1.62e-05	8.12e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—PIK3CB—liver cancer	1.62e-05	8.12e-05	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—AKT1—liver cancer	1.62e-05	8.1e-05	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—PIK3CB—liver cancer	1.62e-05	8.09e-05	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—PIK3CG—liver cancer	1.61e-05	8.06e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—HMOX1—liver cancer	1.6e-05	8.03e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—HPGDS—liver cancer	1.6e-05	7.98e-05	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—PPARA—liver cancer	1.59e-05	7.97e-05	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—MYC—liver cancer	1.57e-05	7.87e-05	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—TGFB1—liver cancer	1.57e-05	7.85e-05	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—PPARG—liver cancer	1.55e-05	7.78e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—CYP1A1—liver cancer	1.55e-05	7.78e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—HRAS—liver cancer	1.55e-05	7.75e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—CDKN1B—liver cancer	1.52e-05	7.62e-05	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR downstream signaling—AKT1—liver cancer	1.51e-05	7.54e-05	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—VEGFA—liver cancer	1.5e-05	7.5e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—GSTM1—liver cancer	1.5e-05	7.48e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—CASP3—liver cancer	1.49e-05	7.47e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—IL2—liver cancer	1.49e-05	7.46e-05	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—STAT3—liver cancer	1.48e-05	7.42e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—IL6—liver cancer	1.48e-05	7.42e-05	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—KRAS—liver cancer	1.45e-05	7.27e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—CCND1—liver cancer	1.45e-05	7.27e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—JUN—liver cancer	1.45e-05	7.25e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—MTHFR—liver cancer	1.45e-05	7.25e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—CTNNB1—liver cancer	1.44e-05	7.2e-05	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.43e-05	7.16e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—PSMA4—liver cancer	1.42e-05	7.12e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—PSMD10—liver cancer	1.42e-05	7.12e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—PPARA—liver cancer	1.42e-05	7.11e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—CYP1A1—liver cancer	1.42e-05	7.09e-05	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—PIK3CD—liver cancer	1.42e-05	7.09e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—MMP9—liver cancer	1.41e-05	7.06e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—CDKN1A—liver cancer	1.41e-05	7.03e-05	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—ALB—liver cancer	1.4e-05	6.99e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—GOT2—liver cancer	1.38e-05	6.92e-05	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—MYC—liver cancer	1.38e-05	6.9e-05	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—TGFB1—liver cancer	1.38e-05	6.88e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—MAPK8—liver cancer	1.37e-05	6.86e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—AKT1—liver cancer	1.37e-05	6.84e-05	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—PIK3CG—liver cancer	1.36e-05	6.82e-05	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—PIK3CA—liver cancer	1.34e-05	6.68e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—MTHFR—liver cancer	1.32e-05	6.61e-05	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—PPARG—liver cancer	1.32e-05	6.59e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—CYP2E1—liver cancer	1.3e-05	6.51e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—PPARA—liver cancer	1.3e-05	6.48e-05	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—TP53—liver cancer	1.29e-05	6.46e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.28e-05	6.39e-05	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—KRAS—liver cancer	1.27e-05	6.37e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—VEGFA—liver cancer	1.27e-05	6.34e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—STAT3—liver cancer	1.25e-05	6.27e-05	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—HRAS—liver cancer	1.24e-05	6.18e-05	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—PIK3CB—liver cancer	1.23e-05	6.18e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—PIK3CG—liver cancer	1.22e-05	6.09e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—CYCS—liver cancer	1.22e-05	6.09e-05	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—PIK3CA—liver cancer	1.21e-05	6.05e-05	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—PIK3CD—liver cancer	1.2e-05	6e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—GGT1—liver cancer	1.19e-05	5.98e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—GOT1—liver cancer	1.19e-05	5.98e-05	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—ALB—liver cancer	1.18e-05	5.92e-05	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—IL6—liver cancer	1.18e-05	5.91e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—PPARG—liver cancer	1.18e-05	5.88e-05	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—PIK3CA—liver cancer	1.17e-05	5.86e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—MYC—liver cancer	1.17e-05	5.83e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.16e-05	5.82e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—TGFB1—liver cancer	1.16e-05	5.82e-05	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—TP53—liver cancer	1.13e-05	5.67e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—PIK3CG—liver cancer	1.11e-05	5.55e-05	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—AKT1—liver cancer	1.09e-05	5.46e-05	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—HRAS—liver cancer	1.08e-05	5.42e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—KRAS—liver cancer	1.08e-05	5.39e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—GSTP1—liver cancer	1.07e-05	5.37e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—PPARG—liver cancer	1.07e-05	5.36e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—PIK3CD—liver cancer	1.07e-05	5.35e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—HMOX1—liver cancer	1.06e-05	5.29e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—ALB—liver cancer	1.06e-05	5.29e-05	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—PIK3CB—liver cancer	1.05e-05	5.23e-05	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—IL6—liver cancer	1.04e-05	5.19e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—PIK3CA—liver cancer	9.89e-06	4.95e-05	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—AKT1—liver cancer	9.88e-06	4.94e-05	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—PIK3CA—liver cancer	9.86e-06	4.93e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—GSTM1—liver cancer	9.86e-06	4.93e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—PIK3CD—liver cancer	9.76e-06	4.88e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—ALB—liver cancer	9.63e-06	4.82e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—TP53—liver cancer	9.57e-06	4.79e-05	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—AKT1—liver cancer	9.56e-06	4.78e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—CYP1A1—liver cancer	9.35e-06	4.68e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—PIK3CB—liver cancer	9.33e-06	4.67e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—HRAS—liver cancer	9.15e-06	4.58e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—IL6—liver cancer	8.76e-06	4.38e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—MTHFR—liver cancer	8.71e-06	4.36e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—PPARA—liver cancer	8.55e-06	4.28e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—PIK3CB—liver cancer	8.51e-06	4.26e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—AKT1—liver cancer	8.08e-06	4.04e-05	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—AKT1—liver cancer	8.06e-06	4.03e-05	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—PIK3CA—liver cancer	7.53e-06	3.76e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—PIK3CG—liver cancer	7.32e-06	3.66e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—PPARG—liver cancer	7.07e-06	3.53e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—PIK3CD—liver cancer	6.44e-06	3.22e-05	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—PIK3CA—liver cancer	6.37e-06	3.19e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—ALB—liver cancer	6.35e-06	3.18e-05	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—AKT1—liver cancer	6.15e-06	3.08e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—PIK3CA—liver cancer	5.69e-06	2.85e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—PIK3CB—liver cancer	5.61e-06	2.81e-05	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—AKT1—liver cancer	5.2e-06	2.6e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—PIK3CA—liver cancer	5.19e-06	2.59e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—AKT1—liver cancer	4.65e-06	2.32e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—AKT1—liver cancer	4.24e-06	2.12e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—PIK3CA—liver cancer	3.42e-06	1.71e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—AKT1—liver cancer	2.79e-06	1.4e-05	CbGpPWpGaD
